CRLvs its industry peers
A metric-by-metric comparison of CRL against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRLThis | — | — | — | — | — | — | — | — | — | — | — | — |
| VRTX | $130.0B#4 | 29.9x#4 | 6.4x#2 | 10.8x#4 | 8.9%#5 | 838.1%#3 | 34.8%#2 | 19.5%#4 | 25.0%#4 | — | 31.1%#4 | — |
| AMGN | $203.5B#2 | 23.4x#3 | 17.4x#4 | 5.5x#2 | 10.0%#4 | 88.5%#5 | 24.7%#6 | 66.0%#2 | 15.1%#5 | — | 41.3%#1 | 2.5%#1 |
| GILD | $183.2B#3 | — | 15.5x#3 | 6.2x#3 | 2.4%#6 | 1672.9%#2 | 34.0%#3 | 71.9%#1 | 26.7%#3 | — | 36.2%#2 | 2.2%#2 |
| REGN | — | 19.2x#2 | — | — | 1.0%#7 | 2.1%#7 | 24.9%#5 | 14.2%#5 | 9.4%#6 | — | 34.7%#3 | — |
| ARGX | $61.0B#5 | — | — | 1715.5x#6 | 254.4%#1 | 55.1%#6 | 2965.7%#1 | — | — | — | — | — |
| ONC | $514.8B#1 | 810.0x#5 | 99.5x#5 | 96.4x#5 | 40.2%#2 | 144.5%#4 | 8.4%#7 | 5.5%#6 | 29.9%#2 | 6#1 | 6.5%#5 | — |
| INCY | $24.9B#6 | 17.6x#1 | 4.4x#1 | 4.8x#1 | 21.2%#3 | 3846.9%#1 | 29.5%#4 | 22.9%#3 | 49.0%#1 | — | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice